| RBGPF | 0% | 74.94 | $ | |
| SCU | 0% | 12.72 | $ | |
| CMSD | 1.18% | 23.63 | $ | |
| RIO | 0.58% | 60 | $ | |
| RYCEF | 2.14% | 14.5 | $ | |
| GSK | 0.32% | 37.68 | $ | |
| BTI | 2.16% | 55.55 | $ | |
| CMSC | 0.87% | 23.07 | $ | |
| RELX | 0.73% | 51.97 | $ | |
| NGG | 1.14% | 72.65 | $ | |
| BCC | -0.77% | 82.71 | $ | |
| SCS | 38.6% | 16.58 | $ | |
| VOD | 0.72% | 11.04 | $ | |
| AZN | 0.86% | 74.59 | $ | |
| JRI | 0.76% | 13.2 | $ | |
| BP | 2.28% | 32.49 | $ | |
| BCE | -1.12% | 23.31 | $ |
Featured
Last news
Forensic Psychiatry at the Frontiers: The Ever-Evolving Challenges of Michael Welner
PITTSBURGH, PA / ACCESS Newswire / February 28, 2025 / Step into some of the most impactful and closely studied cases in forensic psychiatry and forensic science in America over recent decades, and you're likely to find the influential work of Dr. Michael Welner, Chairman of The Forensic Panel. A Professor of Psychiatry at Mt. Sinai School of Medicine, Dr. Welner has most recently been at the heart of court proceedings of highly contested confessions of prisoners at Guantanamo Bay, including the 9-11 mastermind Khalid Sheikh Mohammed and his co-defendants, as well as the accused mastermind of the USS Cole attack in Yemen. These are just the latest examples of Dr. Welner's pivotal role in untangling complex intersections of law, mental health, and forensic science.
Forward Water Technologies Announces December 31, 2024 Financial Results
TORONTO, ON / ACCESS Newswire / February 28, 2025 / Forward Water Technologies Corp. (TSXV:FWTC) (the "Company" or "FWTC")) is pleased to announce that it has filed its condensed consolidated interim financial statements and related management's discussion and analysis for the twelve months ended December 31, 2024. Copies of these financial statements and related management's discussion and analysis can be found on the Company's issuer profile at www.sedarplus.ca. All financial information in this news release is reported in Canadian dollars, unless otherwise indicated.
Avant Brands Reports Record Fiscal 2024 Results
Record Gross and Net Revenue: Generated $40.0 million Gross Revenue and $35.8 million Net Revenue in FY 2024.Record Export Wholesale Revenue: Generated $19.4 million in FY 2024 representing a 107% increase over FY 2023.Record Cannabis Production: 12,643 kilograms produced in FY 2024, representing a 19% increase over FY 2023.Record Cannabis Sold: 13,560 kilograms sold in FY 2024, representing a 91% increase over FY 2023.
Moderna Receives Medicines and Healthcare Products Regulatory Agency Marketing Authorization in the UK for RSV Vaccine
mRESVIA® is Moderna's second approved product in the UK
Survey Reveals Major Gaps in Workplace Support for Women's Midlife Health Needs
WASHINGTON, DC / ACCESS Newswire / February 28, 2025 / New survey findings released today reveal significant gaps between awareness of menopause-related workplace challenges and organizational support for affected employees. The report, "Understanding the Health Issues of Women in Midlife," examines how employers understand and address the difficulties faced by employees in midlife, including women experiencing perimenopause and menopause.
Marco Polo and New to The Street Unite to Transform Global Operations Into Powerful Brand Identities
Bridging the Gap for International Securities Firms
Xtant Medical to Issue Fourth Quarter and Year End 2024 Financial Results on March 6, 2025
BELGRADE, MT / ACCESS Newswire / February 28, 2025 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the fourth quarter and year ended December 31, 2024, after the close of the financial markets on Thursday, March 6, 2025.
Influencer Andrew Tate in US despite charges in Romania
Andrew Tate, a right-wing influencer charged with rape and human trafficking in Romania, arrived in the United States on Thursday -- the first time he has been out of the eastern European country since his 2022 arrest.
Influencer Andrew Tate facing charges in Romania arrives in US
Andrew Tate, a right-wing influencer charged with rape and human trafficking in Romania, arrived in the United States on Thursday, the first time he has been out of the eastern European country since his 2022 arrest.
Accused of repression, Nicaragua's Ortega swears in hooded 'volunteer' force
Nicaraguan President Daniel Ortega, under sanctions for human rights abuses, has sworn in 30,000 hooded civilians as a "volunteer police" force the opposition fears will be used as a tool of political repression.
Hong Kong pro-democracy lawmaker jailed over 2019 mob attack
A Hong Kong court jailed a former pro-democracy lawmaker and six others on Thursday for rioting in relation to a mob attack in 2019, despite lawyers arguing that the men were victims not aggressors.
Caution urged as ailing pope records slight improvement
Pope Francis, battling pneumonia in both lungs, slept well and is resting, the Vatican said Thursday, after revealing the 88-year-old's condition was slightly improving.
North Korea behind $1.5 billion crypto theft, FBI says
The US Federal Bureau of Investigation on Wednesday accused North Korea of being behind the theft of $1.5 billion worth of digital assets last week, the largest crypto heist in history.
'Escaping hell': Myanmar scam centre workers plead to go home
Hundreds of exhausted young men lie in an open-sided detention centre in a seedy Myanmar border town, sweating through thick tropical heat by day and prey to clouds of mosquitoes by night.
'Contemplated suicide': Ethiopians recount horror of SE Asia scam centres
Starved, beaten and electrocuted, Ahmed remains traumatised months after being trafficked to Southeast Asia, one of an untold number of Africans forced to work in scam centres far from home.
Onco-Innovations' Inka Health Innovative AI-Driven Oncology Study Paves the Way for New Research
VANCOUVER, BC / ACCESS Newswire / February 27, 2025 / Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to provide information regarding its wholly-owned subsidiary, Inka Health ("Inka"), which has made significant strides in advancing AI-driven oncology research by leading a transformative study protocol1 published in medRxiv in September 2024, focused on AI-generated synthetic patient models. This innovative research aims to advance the study of oncology by creating synthetic patient data, thereby leveraging advanced machine learning techniques to overcome critical challenges, particularly in the study of rare cancers where traditional patient data is often unavailable or difficult to obtain.
AI to Transform Independent and Assisted Living With Addison Virtual Caregiver
The Competitive Edge in AI-Powered Senior Living
MedMira Announces Partnership with MediGroup Physician Services in the United States
HALIFAX, NS / ACCESS Newswire / February 27, 2025 / MedMira Inc. (MedMira) (TSXV:MIR) announced today its partnership with MediGroup, a leader in the US health care industry since 1999. This new partnership allows the Company to promote and sell its products to over 44,000 existing customers.
Maison Solutions Appoints Jacob Cao as Chief Operating Officer
MONTEREY PARK, CALIFORNIA / ACCESS Newswire / February 27, 2025 / Maison Solutions Inc. (NASDAQ:MSS) ("Maison Solutions" or the "Company"), a U.S.-based specialty grocery retailer offering traditional Asian and international food and merchandise, announced the appointment of Jacob Cao as its new Chief Operating Officer. In this role, Cao will oversee operating strategies with a focus on implementing new policies that aid Maison in its continued strategic expansion.
MAGIC, PROJECT and SOURCING at MAGIC Embrace Emerging Trends, Strengthening Las Vegas Fashion Community
LAS VEGAS, NV / ACCESS Newswire / February 27, 2025 / MAGIC, PROJECT and SOURCING at MAGIC, the leading bi-annual wholesale fashion event, concludes bringing together the men's, women's and sourcing fashion communities to discover and connect with retailers, buyers and industry professionals to increase brand awareness and visibility within the fashion marketplace.
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2024
Reports Net Revenues of $186.5 Million for the Three Months Ended December 31, 2024
Mosaic Announces Fourth Quarter 2024 Results
TAMPA, FL / ACCESS Newswire / February 27, 2025 / The Mosaic Company (NYSE:MOS) released its financial results for fourth quarter 2024. The company's earnings release and supplemental materials are available at https://investors.mosaicco.com/financials/quarterly-results.
Interactive Strength Inc. (Nasdaq:TRNR) Updates FAQ in Response to a High Volume of Shareholder Questions
TRNR details $50M pro forma annual revenue guidance, rationale of expected Sportstech acquisition, comments on market manipulation concerns and bitcoin as a Treasury asset
TPT Global Tech Joins SAMENA Council to Bring VuMe Live Super App and Other High Value Partnership Innovations to Telecom Operators in the SA-ME-NA & Africa Regions
SAN DIEGO, CALIFORNIA / ACCESS Newswire / February 27, 2025 / TPT Global Tech, Inc. www.tptglobaltech.com ("TPTW or the Company") (OTC PINK:TPTW) is pleased to announce that TPT Global Tech has officially joined as a new member of SAMENA Telecommunications Council (www.samenacouncil.org), a leading regional trade association serving as a unified voice for Telecom Operators,. This strategic partnership underscores TPT Global Tech's commitment to driving digital transformation across the Middle East and Africa through its VüMe Live Super App, offering telecom operators a comprehensive platform to enhance customer engagement, improve operational efficiency, and diversify revenue streams.
1933 Industries Announces First Quarter 2025 Financial Report
VANCOUVER, BC / ACCESS Newswire / February 27, 2025 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTC PINK:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce its first quarter financial results ("Q1 2025") for the three months ended October 31, 2024 and 2023. All amounts expressed are in Canadian dollars.
DirectTrust(R) Names Lisa Nelson as Chief Technical Officer
Healthcare industry veteran joins leadership team in fractional capacity to drive innovation in trusted data exchange driven by standards development
The Water and Wastewater Equipment, Treatment and Transport (WWETT) Show Excels Sector, Increasing Access to Essential Education and Products
Top product categories included vacuum trucks, pumps, nozzles, portable sanitation equipment and excavation equipment.
"The Blue Angels" Wins for Outstanding Achievement in Sound Editing for a Feature Documentary at the MPSE Golden Reel Awards
The Blue Angels is recognized among other Golden Reel feature winners, including Wicked, The Wild Robot, Emilia Pérez, Saturday Night, and Dune: Part 2
Xebra Brands Acknowledges COFEPRIS Announcement, Marking a Major Turning Point in Mexico’s Cannabis Industry
VANCOUVER, BC / ACCESS Newswire / February 27, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company"), (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0) a trailblazer in the Mexican cannabis industry, welcomes the latest public announcement from the Federal Commission for the Protection against Sanitary Risks (COFEPRIS), which explicitly condemns the illegal marketing of unregulated CBD and cannabis-derived products in Mexico.
Jaguar Health Adopts Limited Duration Stockholder Rights Plan to Ensure Stockholders Can Realize Long-Term Value
Jaguar expects first results in Q2 2025 of proof-of-concept investigator-initiated trials of crofelemer for the rare diseases short bowel syndrome with intestinal failure and microvillus inclusion diseaseFDA meeting expected in Q2 2025 on the statistically significant results of the Phase 3 OnTarget trial of crofelemer in the prespecified subgroup of patients with breast cancerJaguar has received an indication of interest to acquire the Company
The Global Revolution in Healthcare Driven by GLP-1 Drugs and the role of Lexaria Bioscience
Lexaria executing a triple-pronged strategy in obesity and diabetesSemaglutide recently approved to treat chronic kidney disease
Bionic Bloom Announces Groundbreaking Non-ABA Therapy Framework: Empowerment-Based Integrated Treatment (EBiT)
A Revolutionary, Neurodivergent-Affirming Approach to Mental Health and Well-Being